Qt Imaging Holdings (QTI) Cash from Operations Growth (3y) (2024 - 2026)
Qt Imaging Holdings (QTI) Cash from Operations Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 27.41% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 22.38% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 30.85% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 168.71% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 12.26% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 65.19% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 43.79% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 9.30% |
| 10 | Qt Imaging Holdings | 43.38 Mn | 32.46 Mn | 3.06 Mn | -108.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -108.62% |
| Mar 31, 2026 | -54.40% |
| Dec 31, 2025 | -73.43% |
| Sep 30, 2025 | -44.26% |
| Jun 30, 2025 | -119.23% |
| Mar 31, 2025 | -148.85% |
| Dec 31, 2024 | 3.00% |